Results 81 to 90 of about 54,240 (219)

Takotsubo cardiomyopathy during armed conflict: A case series

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1494-1498, April 2025.
Sharon Bruoha   +13 more
wiley   +1 more source

Clinical significance of obstructive sleep apnea in patients with acute coronary syndrome in relation to diabetes status. [PDF]

open access: yes, 2019
Objective: The prognostic significance of obstructive sleep apnea (OSA) in patients with acute coronary syndrome (ACS) according to diabetes mellitus (DM) status remains unclear. We aimed to elucidate the association of OSA with subsequent cardiovascular
Du, Yunhui   +6 more
core   +1 more source

The Biochemical Aspects of a Non–ST-Segment Elevation Acute Coronary Syndrome

open access: yesReviews in Cardiovascular Medicine, 2012
The clinical course of an acute coronary syndrome can vary from relatively benign to potentially fatal. The biomarkers of myocardial necrosis relate to the amount of myocardial damage and are closely linked to a patient's prognosis. They are measured to help guide management decisions. Recent interest in myocardial neurohumoral
Riezebos, R.K.   +3 more
openaire   +5 more sources

Digital technologies and clinical decision support tools available for diabetes triage in the inpatient setting: A systematic literature review

open access: yesDiabetic Medicine, Volume 43, Issue 3, March 2026.
Abstract Aims People with diabetes who are admitted to hospital are at risk of adverse in‐hospital outcomes due to glycaemic dysregulation. Both the prevalence of diabetes and adverse outcomes are higher in rural and regional hospitals where infrastructure is more limited.
Giuliana Murfet   +7 more
wiley   +1 more source

Zero-Contrast Multivessel Revascularization for Acute Coronary Syndrome in a Patient With Chronic Kidney Disease

open access: yesJACC: Case Reports, 2019
Patients with chronic kidney disease are at elevated risk for adverse events after traditional coronary angiography and percutaneous intervention with contrast media.
Mahesh V. Madhavan, MD   +4 more
doaj   +1 more source

Prevalence of secondary ST-T wave electrocardiographic abnormalities confounding the diagnosis of acute myocardial ischemia in patients presenting to the emergency department with a chief complaint of chest pain [PDF]

open access: yes, 2017
Chest pain in patients presenting to the emergency department (ED) has a plethora of etiologies and electrocardiographic (ECG) manifestations. Admission to the hospital from the ED with chest pain will likely place the patient on a telemetry monitored ...
Rivero, Diana
core  

Sex differences in trial representation and the cardiovascular effectiveness of newer glucose‐lowering agents in patients with and without type 2 diabetes: A systematic review and meta‐analysis of cardiovascular outcome trials

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 2183-2202, March 2026.
Abstract Aims The extent to which the cardiovascular benefits of sodium–glucose co‐transporter 2 inhibitors (SGLT‐2is) and glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) differ by sex remains unclear. This systematic meta‐analysis aimed to investigate sex differences in trial representation and the cardiovascular and kidney efficacy of SGLT‐2is ...
Magdaline Zawadka   +6 more
wiley   +1 more source

Access and non–access site bleeding after percutaneous coronary intervention and risk of subsequent mortality and major adverse cardiovascular events:Systematic review and meta-analysis [PDF]

open access: yes, 2015
Background: The prognostic impact of site-specific major bleeding complications after percutaneous coronary intervention (PCI) has yielded conflicting data.
Buchan, Iain   +10 more
core   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 329-347, February 2026.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo   +22 more
wiley   +1 more source

DISPERSIÓN DEL INTERVALO QT CORREGIDO EN LA EVOLUCIÓN DE PACIENTES CON SÍNDROMES CORONARIOS AGUDOS / Corrected QT interval dispersion in the evolution of patients with acute coronary syndromes [PDF]

open access: yesCorSalud, 2011
Introduction and Objectives: Acute myocardial infarc-tion remains a major challenge for health systems. In the classic concept of the ischemic cascade, the earliest event is the QT interval prolongation, which was previously reported in patients with ...
Carlos J. Fabelo Mora   +5 more
doaj  

Home - About - Disclaimer - Privacy